CRKL and chronic myelogenous leukemia, BCR-ABL1 positive: The results of CrkL assay confirmed that IS3 blockade-induced CML cell killing effect is mediated through BCR-ABL1 inhibition both in wild-type and mutant type CML cell lines including BaF3/T315Imut cells (Supplementary Fig. 7).